FOXO1 determines Non-Hodgkin lymphomas reponse to anti-CD20-based therapy.
Authors: Zerrouqi A., Pyrzynska B., Dwojak M., Morlino G., Zapala P., Miazek N., Golab J., Winiarska M.
Published in: AACR Special Conference on Advances in modeling cancer in mice: technology, biology, and beyond
Publication type: conference